Abstract:
Disclosed are concentrated, liquid, human milk fortifier compositions comprising from about 15% to about 45% by weight of protein, on a dry weight basis, and having a caloric density of from about 1.25 kcal/ml to about 6.0 kcal/ml, wherein the liquid human milk fortifier composition is added to human milk in a volume-volume ratio of from about 1:3 to about 1:9. These composition include embodiments comprising carbohydrate and fat, that are formulated with improved stability by selecting any one of the following variations: 1) certain whey-casein protein blends, 2) water insoluble calcium-containing materials, 3) protein hydrolysates, and 4) aseptically packaged concentrates. The liquid concentrates are especially useful for providing nutrition to preterm infants in neonatal intensive care units or similar other institutional setting, and to minimize the risk of introducing microbial contaminants such as Enterobacter sakazakii to infant feedings during preparation in such institutional settings.
Abstract:
A smoking article such as a cirgarette, or a smoke filter (3) or other component thereof, comprises a catalyst (3b) for the oxidation of carbon monoxide to carbon dioxide. The catalyst (3b) comprises gold, and an oxide of zinc or titanium. Titania and mixed oxides of zinc and copper or aluminium are preferred (TiO 2 , ZnO, ZnA1O x or CuZnO x ). The gold preferably comprises species in the metallic state (Au 0 ), together with species in an oxiddise state (Au d+ ).
Abstract translation:吸烟物品如香茅或烟雾过滤器(3)或其它组分包括用于将一氧化碳氧化成二氧化碳的催化剂(3b)。 催化剂(3b)包含金和锌或钛的氧化物。 二氧化钛和锌和铜或铝的混合氧化物是优选的(TiO 2,ZnO,ZnAlO x x或CuZnO x x)。 金优选包含处于金属状态的物质(Au O),以及处于氧化状态的物质(Au + D + +)。
Abstract:
A smoking article such as a cirgarette, or a smoke filter (3) or other component thereof, comprises a catalyst (3b) for the oxidation of carbon monoxide to carbon dioxide. The catalyst (3b) comprises gold, and an oxide of zinc or titanium. Titania and mixed oxides of zinc and copper or aluminium are preferred (TiO 2 , ZnO, ZnA1O x or CuZnO x ). The gold preferably comprises species in the metallic state (Au 0 ), together with species in an oxiddise state (Au δ+ ).
Abstract:
A ready-to-drink formulation in bottled form comprises still spring water, an active ingredient, one or more flavouring agents, one or more sweeteners and an organic acid, the formulation having a shelf-life in excess of six months. The formulations have excellent oganoleptic properties and a shelf life which is generally in excess of twelve months, while at the same time acting as a vehicle for a range of active ingredients which have a functional effect. Thus, the active ingredient can be a combination of saccharide materials and salts which can be used by consumers to boost their energy levels throughout the day during normal work and recreation, but also in situations where extra energy is required, such as when engaging in strenuous activity, for example sporting activities. The active ingredient can also be potassium hydroxycitric acid, a known appetite suppressant, such that the formulation can have beneficial effects for those wishing to reduce their calorie intake and thus achieve weight loss.
Abstract:
A beverage which comprises a fruit juice product, a supplement selected from the group consisting of vitamin supplements and mineral supplements or combinations thereof, a flavoring agent, an additive selected from the group consisting of an edible acid and an edible salt or combinations thereof, and water, the pH of the beverage being least about 5.0. The juice is found to be of benefit when recovering from surgery, illness such as glandular fever and chronic fatigue conditions.
Abstract:
A composition is disclosed which comprises as characterizing active ingredients propionyl L-carnitine and a flavonoid, typically quercetin or its 3-rutinoside, rutin, for the prevention and/or therapeutic treatment of various alterations and pathological states induced by free radicals and by thrombotic or atherosclerotic abnormalities, that may take the form of a dietary supplement, dietetic support or of an actual medicine.
Abstract:
This invention is directed to a dietary regimen and a unique combination of nutritional supplements and a method. More specifically, this invention is directed to a unique combination of nutritional supplements which provides symptomatic relief from arthritis. The unique combination of nutritional supplements of this invention is believed to function by both increasing the available (effective blood level) of anti-inflammatory agents and promotion of the healing/regenerative process in the effected joints, thus, producing unexpected and lasting symptomatic relief from the debilitating effects of both osteoarthritis and rheumatoid arthritis. The essential nutritional supplements of the dietary regimen of this invention are as follows: (a) gamma linolenic acid (unrefined), hereinafter "GLA"; (b) a mixture of eicosapentaenoic acid and docosahexaneoic acid, hereinafter collectively "EPA"; (c) a mixture of chondroitin sulfate, N-acetyl glucosamine sulfate, glucosamine sulfate and manganese aspartate, hereinafter collectively "CHONDROX". The regimen is adjusted based upon the weight of the individual, and once symptomatic relief is achieved, the individual remains essentially free from the debilitating effects of arthritis so as long the daily regimen is faithfully followed.
Abstract:
The invention is a dietary food enhancement agent for fortifying food products. Calcium is supplied by a combination of calcium citrate and dicalcium phosphate, the phosphorus is supplied by a combination of dicalcium phosphate and magnesium phosphate, and the magnesium is supplied by magnesium phosphate. The agent may further comprise, Vitamin A, Vitamin B1, Vitamin B2, Vitamin B3, Vitamin B6, Vitamin B12, Vitamin C, Vitamin D, Vitamin E, Vitamin K, Biotin, Copper, Folic Acid, Iodine, Iron, Manganese, Pantothenic Acid, and Zinc.
Abstract:
A nutritional or dietary supplement composition that strengthens and promotes a general eye health benefit for aging adults, including retinal health through the prevention, stabilization, reversal and/or treatment of visual acuity loss by reducing the risk of developing late stage or advanced age-related macular degeneration in persons with early age-related macular degeneration. The nutritional or dietary supplement composition may likewise reduce the risk of vision loss associated with the development of cataracts.
Abstract:
The present invention disclpses a nutritious, tasty and affordable drink made from the sap of Kappaphycus alvarezii seaweed which is readily cultivable. The drink resembles coconut water in appearance and taste and is rich in potassium. It also contains an adequate proportion of the daily requirement of iodine besides many other useful minerals such as magnesium, calcium, sodium, zinc, phosphorous and iron while having low concentrations of toxic elements such as lead and chromium. The process of refining sap, which enables the seaweed drink to be palatable and widely acceptable, besides bestowing adequate shelf life, is also described. The process of preparation is integrated with preparation of carrageenan and plant nutrient thereby making optimum use of the seaweed and minimizing waste.